冠心宁片联合西药治疗冠心病合并轻度高血压病临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.4;R544.1

基金项目:

浙江省医学会临床科研资金项目(2019ZYC-A31)


Clinical Study on Guanxinning Tablets Combined with Western Medicine for Coronary Heart Disease Complicated with Mild Hypertension
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察冠心宁片联合西药治疗冠心病合并轻度高血压病的临床疗效。方法:选取150 例冠心病合并轻度高血压病患者,按随机数字表法分为对照组及观察组各75 例。对照组采用常规西药治疗,观察组在对照组基础上加用冠心宁片治疗。比较2 组临床疗效,比较2 组治疗前后心绞痛发作频率、持续时间、血压、血管内皮功能指标[一氧化氮(NO)、血栓素B2(TXB2)、内皮素-1(ET-1)]、炎症因子[白细胞介素-6 (IL-6)、超敏C-反应蛋白(hs-CRP)、白细胞介素-10 (IL-10)]、血液流变学指标[红细胞比容(HCT)、全血高切黏度(BVH)、血浆黏度(PV)] 的变化。结果:治疗后,观察组临床疗效总有效率为96.00%,对照组为86.67%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组心绞痛发作频率、持续时间较治疗前下降,差异均有统计学意义(P<0.05);治疗后,观察组心绞痛发作频率、持续时间均低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组收缩压、舒张压水平均较治疗前下降,观察组2 项水平均低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组NO 水平均较治疗前升高,TXB2、ET-1 水平均较治疗前下降,差异均有统计学意义(P<0.05);治疗后,观察组NO 水平高于对照组,TXB2、ET-1 水平均低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组IL-6、hs-CRP 水平均较治疗前降低,IL-10 水平均较治疗前升高,差异均有统计学意义(P<0.05);治疗后,观察组IL-6、hs-CRP 水平均低于对照组,IL-10水平高于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组BVH、PV、HCT 指标值均较治疗前下降,观察组上述3 项指标值均低于对照组,差异均有统计学意义(P<0.05)。治疗期间,2 组均未出现严重药物不良反应病例。结论:冠心宁片联合西药治疗冠心病合并轻度高血压病疗效显著,可有效改善患者血管内皮功能及血液流变学,减轻机体炎症反应。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Guanxinning tablets combined with western medicine for coronary heart disease complicated with mild hypertension. Methods:A total of 150 cases of patients with coronary heart disease complicated with mild hypertension were selected and divided into the control group and the observation group according to the random number table method,with 75 cases in each group. The control group was treated with routine western medicine,and the observation group was additionally treated with Guanxinning tablets based on the treatment of the control group. The clinical effects in the two groups were compared. Before and after treatment,the changes in frequency and duration of angina pectoris attack, blood pressure, vascular endothelial function indexes including nitric oxide(NO), thromboxane B2(TXB2) and endothelin- 1(ET- 1), inflammatory factors including interleukin- 6(IL- 6), hypersensitive C-reactive protein(hs-CRP) and interleukin-10(IL-10),and hematocrit(HCT),whole blood high shear viscosity(BVH) and plasma viscosity(PV) in the two groups were compared. Results: After treatment,the total effective rate of clinical effect was 96.00% in the observation group and 86.67% in the control group, the difference being significant(P<0.05). After treatment, the frequency and duration of angina pectoris attack in the two groups were decreased when compared with those before treatment, differences being significant(P<0.05). After treatment,frequency and duration of angina pectoris attack in the observation group were lower than those in the control group,differences being significant(P<0.05). After treatment,the levels of systolic blood pressure and diastolic blood pressure in the two groups were decreased when compared with those before treatment,and the above two levels in the observation group were lower than those in the control group, differences being significant(P<0.05). After treatment, the levels of NO in the two groups were increased when compared with those before treatment,and the levels of TXB2 and ET- 1 were decreased, differences being significant(P<0.05). After treatment, the level of NO in the observation group was higher than that in the control group,and the levels of TXB2 and ET- 1 were lower,differences being significant(P<0.05). After treatment,the levels of IL-6 and hs-CRP in the two groups were decreased when compared with those before treatment, and IL- 10 levels were increased,differences being significant(P<0.05). After treatment,the levels of IL- 6 and hs- CRP in the observation group were lower than those in the control group, and IL- 10 level was higher, differences being significant(P<0.05). After treatment, the values of BVH, PV and HCT in the two groups were decreased when compared with those before treatment,and the values of the above three indexes in the observation group were lower than those in the control group, differences being significant(P<0.05). During the treatment, no serious adverse drug reaction occurred in the two groups. Conclusion: The therapy of Guanxinning tablets combined with western medicine for coronary heart disease complicated with mild hypertension has a significant curative effect, which can effectively improve the vascular endothelial function and hemorheology of patients,and relieve systemic inflammatory responses.

    参考文献
    相似文献
    引证文献
引用本文

田祖云.冠心宁片联合西药治疗冠心病合并轻度高血压病临床研究[J].新中医,2022,54(18):35-39

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-09-28
  • 出版日期:
文章二维码